相关实验视频

Updated: Jun 12, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.2K

在HER2-低乳腺癌患者中有害生殖系变异的频率使用遗传多面板基因测试

Janaina Pontes Batista Cassoli1,2, Ítalo Fernandes2, Leonardo Carvalho1

  • 1Center for Personalized Medicine, Hospital Israelita Albert Einstein, São Paulo 05652000, Brazil.

Current issues in molecular biology
|August 28, 2024
PubMed
概括

致病性生殖系变异 (PGVs) 在HER2-低乳腺癌 (BC) 患者中比其他BC类型更为常见. 对于HER2-Low BC患者,建议对这些变异进行基因检测.

关键词:
这就是BRCA BRCA.在HER2-低的水平下.乳腺癌 乳腺癌 乳腺癌遗传学 遗传学 遗传学 是一个生殖线遗传检测试验的生殖线遗传检测.

更多相关视频

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

12.6K

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...